Publications by authors named "Marc Polus"

Claim this Profile
D
Digenic Inheritance of Mutations in Homologous Recombination Genes in Cancer Patients.
Maria Valeria Freire, Marie Martin, Karin Segers, Edith Sepulchre, Natacha Leroi, Marc Polus

J Pers Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncological patients' reactions to COVID-19 pandemic: A single institution prospective study.
Concetta Elisa Onesti, Hélène Schroeder, Andrée Rorive, Brieuc Sautois, Marie Lecocq, Marc Polus

Cancer Rep (Hoboken)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia-Brussels colorectal cancer screening programme.
Feng Guo, Isabel De Brabander, Julie Francart, Michel Candeur, Marc Polus

Br J Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia-Brussels colorectal cancer screening programme.
Feng Guo, Isabel De Brabander, Julie Francart, Michel Candeur, Marc Polus

Br J Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer.
Pierre Lovinfosse, Marc Polus, Daniel Van Daele, Philippe Martinive, Frédéric Daenen

Eur J Nucl Med Mol Imaging· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of cinacalcet and sunitinib to treat hypercalcaemia due to a pancreatic neuroendocrine tumor.
Hernan Valdes-Socin, Matilde Rubio Almanza, Mariana Tomé Fernández-Ladreda, Daniel Van Daele, Marc Polus

Arch Endocrinol Metab· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OLFM4, KNG1 and Sec24C identified by proteomics and immunohistochemistry as potential markers of early colorectal cancer stages.
Florence Quesada-Calvo, Charlotte Massot, Virginie Bertrand, Rémi Longuespée, Noëlla Blétard, Marc Polus

Clin Proteomics· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status.
Pierre Lovinfosse, Benjamin Koopmansch, Frederic Lambert, Sébastien Jodogne, Gaelle Kustermans, Marc Polus

Br J Radiol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.

Ann Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma.
Raphaël Maréchal, John R Mackey, Raymond Lai, Pieter Demetter, Marc Peeters, Marc Polus

Cancer· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study.
Jean-Luc Van Laethem, Pascal Hammel, Françoise Mornex, David Azria, Geertjan Van Tienhoven, Marc Polus

J Clin Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma.
Raphaël Maréchal, John R Mackey, Raymond Lai, Pieter Demetter, Marc Peeters, Marc Polus

Clin Cancer Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib for the treatment of patients with unresectable or metastatic malignant KIT-positive gastrointestinal stromal tumours: an open-label Belgian trial.
Hans Prenen, Herlinde Dumez, Cristiana Stefan, Ann Hoeben, Carine Wouters, Marc Polus

Acta Gastroenterol Belg· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carcinoid tumor of the appendix: a consecutive series from 1237 appendectomies.
Vincent Tchana-Sato, Olivier Detry, Marc Polus, Albert Thiry, Bernard Detroz

World J Gastroenterol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter Belgian Phase II study.
Anne Demols, Marc Peeters, Marc Polus, Pierre Honoré, T Boterberg

Int J Radiat Oncol Biol Phys· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study.
Jean-Luc Van Laethem, Anne Demols, France Gay, Marie-Thérèse Closon, Maryvone Collette, Marc Polus

Int J Radiat Oncol Biol Phys· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis